These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 9198809)
21. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma. Kelloway JS Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243 [TBL] [Abstract][Full Text] [Related]
22. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Bisgaard H Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935 [TBL] [Abstract][Full Text] [Related]
23. Leukotrienes as mediators of airway obstruction and inflammation in asthma. Dahlén B; Dahlén SE Clin Exp Allergy; 1995 Nov; 25 Suppl 2():50-4. PubMed ID: 8590344 [No Abstract] [Full Text] [Related]
24. The role of antileukotrienes in asthma management. Tan RA Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901 [TBL] [Abstract][Full Text] [Related]
25. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Roquet A; Dahlén B; Kumlin M; Ihre E; Anstrén G; Binks S; Dahlén SE Am J Respir Crit Care Med; 1997 Jun; 155(6):1856-63. PubMed ID: 9196086 [TBL] [Abstract][Full Text] [Related]
26. [Leukotriene modifiers in the treatment of asthma]. Alvarez J Rev Alerg Mex; 1999; 46(3):72-7. PubMed ID: 10425884 [TBL] [Abstract][Full Text] [Related]
27. Bronchoprotective effects of leukotriene receptor antagonists in asthma: a meta-analysis. Currie GP; Lipworth BJ Chest; 2002 Jul; 122(1):146-50. PubMed ID: 12114350 [TBL] [Abstract][Full Text] [Related]
28. Leukotriene receptor antagonists. Altinger JA Lippincotts Prim Care Pract; 1998; 2(6):634-42. PubMed ID: 9883158 [No Abstract] [Full Text] [Related]
29. [Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class]. Santais MC; Callens E; Djebbar R; Ruff F Rev Med Interne; 1998 Feb; 19(2):98-107. PubMed ID: 9775124 [TBL] [Abstract][Full Text] [Related]
30. [Leukotriene antagonists: a new approach in the treatment of asthma]. Devillier P; Bessard G; Advenier C Rev Mal Respir; 1997 Jun; 14(3):159-70. PubMed ID: 9411593 [TBL] [Abstract][Full Text] [Related]
33. Asthma outcome changes associated with use of the leukotriene-receptor antagonist zafirlukast. Klingman D; Bielory L; Wang Y; Silverman S; Bell CF; Joy KA; Dever MT; Jones DA Manag Care Interface; 2001 Feb; 14(2):62-6. PubMed ID: 11228819 [TBL] [Abstract][Full Text] [Related]
34. Leukotriene antagonists. Do they offer new hope for asthmatics? Thien F Aust Fam Physician; 2000 Jun; 29(6):547-51. PubMed ID: 10863810 [TBL] [Abstract][Full Text] [Related]
35. Antileukotriene agents in asthma: the dart that kills the elephant? Renzi PM CMAJ; 1999 Jan; 160(2):217-23. PubMed ID: 9951445 [TBL] [Abstract][Full Text] [Related]
36. The use of leukotriene modifying drugs in asthma and other respiratory diseases. Corless JA; Paracha M Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):271-5. PubMed ID: 14561192 [TBL] [Abstract][Full Text] [Related]
37. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Drazen J Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S233-7; discussion S247-8. PubMed ID: 9647605 [TBL] [Abstract][Full Text] [Related]
38. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. Holgate ST; Bradding P; Sampson AP J Allergy Clin Immunol; 1996 Jul; 98(1):1-13. PubMed ID: 8765812 [TBL] [Abstract][Full Text] [Related]
39. [Leukotriene receptor antagonists]. Bornkessel B Med Monatsschr Pharm; 1996 Oct; 19(10):284-6. PubMed ID: 9011771 [No Abstract] [Full Text] [Related]